PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+11.15%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$457M
AUM Growth
+$457M
(+10%)
Cap. Flow
+$32.2M
Cap. Flow
% of AUM
7.05%
Top 10 Holdings %
Top 10 Hldgs %
38.17%
Holding
99
New
16
Increased
39
Reduced
27
Closed
16
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$18M |
| 2 |
Repligen
RGEN
|
$7.73M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.13M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$5.93M |
| 5 |
Protagonist Therapeutics
PTGX
|
$5.83M |
Top Sells
| 1 |
Amgen
AMGN
|
$11.2M |
| 2 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$5.13M |
| 3 |
Vericel Corp
VCEL
|
$4.71M |
| 4 |
Arrowhead Research
ARWR
|
$4.65M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
$3.98M |
Sector Composition
| 1 | Healthcare | 95.62% |
| 2 | Technology | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aclaris Therapeutics
ACRS
$209M
| $26.4M | 5.76% | 1,501,460 -207,676 | -12% | -$3.65M |
|
2
DexCom
DXCM
$29.5B
| $21.5M | 4.71% | 50,458 +12,740 | +34% | +$5.44M |
|
3
Charles River Laboratories
CRL
$8.04B
| $19.3M | 4.22% | 52,245 +2,245 | +4% | +$830K |
|
|
4
Intuitive Surgical
ISRG
$170B
| $18M | 3.94% | +19,613 | New | +$18M |
|
5
United Therapeutics
UTHR
$13.8B
| $16.9M | 3.7% | 94,324 +19,450 | +26% | +$3.49M |
|
6
IQVIA
IQV
$32.4B
| $16.6M | 3.62% | 68,369 +2,321 | +4% | +$562K |
|
7
Danaher
DHR
$147B
| $15M | 3.27% | 55,824 -9,161 | -14% | -$2.46M |
|
8
Humana
HUM
$36.5B
| $14.5M | 3.16% | 32,681 -319 | -1% | -$141K |
|
9
Natera
NTRA
$23.1B
| $13.7M | 2.99% | 120,547 -19,346 | -14% | -$2.2M |
|
10
Alnylam Pharmaceuticals
ALNY
$58.5B
| $12.7M | 2.78% | 74,967 +9,924 | +15% | +$1.68M |
|
11
Avantor
AVTR
$9.18B
| $12.6M | 2.75% | 353,941 +101,778 | +40% | +$3.61M |
|
|
CDMO
12
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $12.2M | 2.66% | 475,000 -200,000 | -30% | -$5.13M |
|
|
DRNA
13
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $11.4M | 2.49% | 304,686 +1,418 | +0.5% | +$52.9K |
|
14
Insulet
PODD
$23.9B
| $9.7M | 2.12% | 35,340 +4,171 | +13% | +$1.14M |
|
|
ICAD
15
DELISTED
iCAD Inc
ICAD
| $9.2M | 2.01% | 531,255 -116,876 | -18% | -$2.02M |
|
|
ITMR
16
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $7.96M | 1.74% | 338,001 +1,572 | +0.5% | +$37K |
|
|
17
Repligen
RGEN
$6.88B
| $7.73M | 1.69% | +38,740 | New | +$7.73M |
|
|
XLRN
18
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.54M | 1.65% | 60,074 -2,706 | -4% | -$340K |
|
19
Xenon Pharmaceuticals
XENE
$2.98B
| $7.47M | 1.63% | 401,207 +26,812 | +7% | +$499K |
|
20
Cooper Companies
COO
$13.4B
| $7.37M | 1.61% | 18,588 +11,088 | +148% | +$4.39M |
|
|
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.13M | 1.56% | +45,176 | New | +$7.13M |
|
22
Dentsply Sirona
XRAY
$2.85B
| $6.99M | 1.53% | 110,455 +60,455 | +121% | +$3.82M |
|
23
Arcus Biosciences
RCUS
$1.13B
| $6.77M | 1.48% | 246,637 -69,245 | -22% | -$1.9M |
|
|
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.77M | 1.48% | 72,267 +3,837 | +6% | +$359K |
|
25
Stereotaxis
STXS
$261M
| $6.55M | 1.43% | 679,082 +3,160 | +0.5% | +$30.5K |
|